Trial Profile
Phase II Study of 99mTc-glucarate in Chest Pain Patients Suspected With ACS With no Obvious Signs of AMI and With Known Previous CAD.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Tc 99m glucarate (Primary)
- Indications Acute coronary syndromes
- Focus Diagnostic use
- Sponsors Molecular Targeting Technologies
- 11 Jun 2014 New trial record